Viewing nowDitra Tablet (Itraconazole Solid Dispersion)
Itraconazole Solid Dispersions 253mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201502419 · Approved 2015.04.23 · Insurance code 693901460
Treatment of skin and nail fungal infections, mucosal and corneal fungal infections, and systemic fungal infections
This medicine is used to treat various fungal diseases, such as candidiasis, tinea, and fungal infections of the skin and nails. It is also effective against oral candidiasis and fungal keratitis. Additionally, it is used for the treatment of systemic fungal infections such as aspergillosis, candidiasis, cryptococcosis, and paracoccidioidomycosis. This drug helps to improve various fungal infections affecting the skin, mucous membranes, and systemic areas.
It is preferable to administer immediately after a meal. 1. Short-term treatment 1) Vulvovaginal candidiasis: Administer itraconazole 200 mg twice daily (morning and evening) for 1 day, or 200 mg once daily for 3 days. 2) Pityriasis versicolor: Administer 200 mg once daily for 7 days. 3) Tinea corporis, tinea cruris (jock itch): Administer 100 mg once daily for 15 days. 4) Tinea manuum (interdigital type), tinea pedis (interdigital type): Administer 100 mg once daily for 15 days. 5) Tinea manuum (palmar), tinea pedis (plantar): Administer 100 mg once daily for 30 days or 200 mg twice daily for 7 days. 6) Oral candidiasis: Administer 100 mg once daily for 15 days. 7) Fungal keratitis: Administer 200 mg once daily for 21 days. 2. Onychomycosis 1) Pulse therapy Administer 200 mg twice daily for 1 week, followed by 3 weeks without treatment; this constitutes 1 cycle. Administer up to 2 cycles for fingernail infections only and up to 3 cycles for toenail infections. 2) Continuous therapy Administer 200 mg once daily for 3 months. The therapeutic effect continues for 3 months for fingernails and 6 months for toenails after treatment ends. 3. Systemic fungal infections In patients with impaired immune function, such as those with neutropenia, AIDS, or organ transplants, the oral bioavailability of this medicine may be reduced; if necessary, double the dose. Aspergillosis: 200mg once daily; average treatment duration 2~5 months. For invasive or disseminated disease, increase to 200mg twice daily. Candidiasis: 100~200mg once daily; average treatment duration 3 weeks~7 months. Cryptococcal meningitis: 200mg twice daily; average treatment duration 2 months~1 year. Maintenance therapy: 200mg once daily. Paracoccidioidomycosis: 100mg once daily; average treatment duration 6 months.
This drug may pose a risk to patients with impaired cardiac function or a history of heart failure, and should not be administered unless for life-threatening infections. Treatment should be discontinued immediately if signs of congestive heart failure appear. Patients with hypersensitivity to this drug, those with specific cardiac, renal, or liver diseases, pregnant or breastfeeding women should not take this medication. Additionally, this drug has significant interactions with various medications, so consultation with a doctor or pharmacist is essential if taken with specific drugs. Patients with reduced liver function may be affected by the metabolism of this drug and should undergo regular liver function tests, with dosage adjustments if necessary. Caution is also advised when administering to patients with reduced kidney function, considering dosage adjustments. Rarely, serious side effects such as liver damage, allergic reactions, neurological abnormalities, and hearing loss may occur, and any unusual symptoms should be reported to medical professionals immediately. Dizziness, vision impairment, and hearing loss may occur, and caution is advised when driving or operating machinery. Women who are pregnant or may become pregnant should not take this medication, and effective contraceptive measures must be used after taking the drug. Breastfeeding women should also discontinue nursing if taking this drug. Caution is advised when administering to children or the elderly, only using when the benefits outweigh the risks. In cases of overdose, as there is no specific antidote, treatment should be symptomatic, and this drug is not removed by hemodialysis. Keep this medicine out of reach of children and store in the original container to prevent misuse or deterioration of quality.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to prevent air exposure and at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the effectiveness and prevent deterioration of the drug.
White or yellowish round film-coated tablets
28 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowItraconazole Solid Dispersions 253mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Itraconazole Solid Dispersions
Prescription medication
JW Pharmaceutical Corporation
Itraconazole Solid Dispersions
Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Itraconazole Solid Dispersions 253mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Itraconazole Solid Dispersions 253mg
Tablet · Prescription medication
IYON Pharmaceutical Co., Ltd.

Itraconazole Solid Dispersions 253mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Itraconazole Solid Dispersions 253mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Itraconazole Solid Dispersions 253mg
Tablet · Prescription medication
Allico Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.